EP415/#978 The modified 5-item frailty index (MFI-5) is a predictor of postoperative complications in vulvar cancer: a national surgical quality improvement program (NSQIP) analysis. (4th December 2022)
- Record Type:
- Journal Article
- Title:
- EP415/#978 The modified 5-item frailty index (MFI-5) is a predictor of postoperative complications in vulvar cancer: a national surgical quality improvement program (NSQIP) analysis. (4th December 2022)
- Main Title:
- EP415/#978 The modified 5-item frailty index (MFI-5) is a predictor of postoperative complications in vulvar cancer: a national surgical quality improvement program (NSQIP) analysis
- Authors:
- Levine, Monica
Felix, Ashley
Meade, Caitlin
Chambers, Laura - Abstract:
- Abstract : Objectives: Frailty is a known predictor of post-operative morbidity, but the impact in women with vulvar cancer is unknown. Our objective was to determine whether frailty is associated with postoperative morbidity following radical vulvectomy (RV). Methods: Using the National Surgical Quality Improvement Program (NSQIP) database, women who underwent RV from 2014–2020 were identified. Frailty was defined utilizing the modified Frailty Index (mFI-5) assessing diagnoses of congestive heart failure, chronic obstructive pulmonary disease, diabetes mellitus, hypertension requiring medication and partial/total functional dependence. Patients were categorized as non-frail (0–1) or frail (2+). Multivariable-adjusted logistic regression analyses were performed. Results: Of 886 women, 49.9% underwent RV alone, and 19.5% and 30.6% concurrent unilateral or bilateral inguinofemoral lymphadenectomy (IFLND), respectively. 24.5% had mFI ≥2 and were considered frail. Compared to non-frail women, frail women were more likely to have an unplanned readmission (7.8% vs 12.9%, p=0.02), wound disruption (4.2% vs. 8.3%, p=0.02), and deep surgical site infection (1.4% vs. 3.7%, p=0.04). On multivariable-adjusted models, frailty was a significant predictor for minor (OR=1.58, 95% CI= 1.09, 2.30) and any complications (OR= 1.46, 95% CI= 1.02, 2.08). Specifically, for RV with bilateral IFLND, frailty was significantly associated with major (OR= 2.13, 95% CI= 1.03, 4.40) and any complicationsAbstract : Objectives: Frailty is a known predictor of post-operative morbidity, but the impact in women with vulvar cancer is unknown. Our objective was to determine whether frailty is associated with postoperative morbidity following radical vulvectomy (RV). Methods: Using the National Surgical Quality Improvement Program (NSQIP) database, women who underwent RV from 2014–2020 were identified. Frailty was defined utilizing the modified Frailty Index (mFI-5) assessing diagnoses of congestive heart failure, chronic obstructive pulmonary disease, diabetes mellitus, hypertension requiring medication and partial/total functional dependence. Patients were categorized as non-frail (0–1) or frail (2+). Multivariable-adjusted logistic regression analyses were performed. Results: Of 886 women, 49.9% underwent RV alone, and 19.5% and 30.6% concurrent unilateral or bilateral inguinofemoral lymphadenectomy (IFLND), respectively. 24.5% had mFI ≥2 and were considered frail. Compared to non-frail women, frail women were more likely to have an unplanned readmission (7.8% vs 12.9%, p=0.02), wound disruption (4.2% vs. 8.3%, p=0.02), and deep surgical site infection (1.4% vs. 3.7%, p=0.04). On multivariable-adjusted models, frailty was a significant predictor for minor (OR=1.58, 95% CI= 1.09, 2.30) and any complications (OR= 1.46, 95% CI= 1.02, 2.08). Specifically, for RV with bilateral IFLND, frailty was significantly associated with major (OR= 2.13, 95% CI= 1.03, 4.40) and any complications (OR= 2.10, 95% CI= 1.14, 3.87). Conclusions: In this NSQIP analysis, one-quarter of women undergoing RV were considered frail. Notably, frailty was associated with increased post-operative complications, especially in women concurrently undergoing bilateral IFLND. Frailty screening prior to RV may assist in patient counseling and improve postoperative outcomes. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 32(2022)Supplement 3
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 32(2022)Supplement 3
- Issue Display:
- Volume 32, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 32
- Issue:
- 3
- Issue Sort Value:
- 2022-0032-0003-0000
- Page Start:
- A221
- Page End:
- A221
- Publication Date:
- 2022-12-04
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2022-igcs.504 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24965.xml